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Abstract: The issue of pharmaceuticals and personal care products (PPCPs) in the water environment
has gained increasing interest worldwide. To determine the nature and extent of this problem
for Poland, this paper presents a review of research on the presence of PPCPs in Poland, looking
at results for different water samples, including wastewater (before and after treatment), landfill
leachate, surface water (standing water bodies and rivers), seawater, groundwater and drinking
water. The review is based on over 50 scientific articles and dissertations referring to studies of
PPCPs. It also briefly outlines possible sources and the fate of PPCPs in the aquatic environment. The
review of Polish research has revealed that studies have previously covered at least 39 PPCP groups
(270 compounds in total). These studies focused mainly on wastewater and rivers, and only a few
concerned landfill leachate and seawater. They most often reported on nonsteroidal anti-inflammatory
drugs and antibiotics. The highest concentrations of the analysed PPCPs were found mainly in raw
wastewater (e.g., naproxen, up to 551,960 ng/L), but they were also occasionally found in surface
water (e.g., azithromycin, erythromycin, irbesartan and metoprolol) and in groundwater (e.g., N,N-
diethyl-meta-toluamide, known as DEET, up to 17,280 ng/L). Extremely high concentrations of
bisphenol A (up to 2,202,000 ng/L) and diclofenac (up to 108,340 ng/L) were found in landfill
leachate. Although numerous substances have been detected, PPCPs are still not monitored regularly,
which makes it difficult to obtain a clear understanding of their incidence in the water environment.
Keywords: PPCPs; emerging contaminants; wastewater; surface water; groundwater; water quality
1. Introduction
The problem of pharmaceuticals and personal care products (PPCPs) in the water
environment has gained increasing interest worldwide in the past two decades [1–4].
PPCPs belong to a large group of emerging contaminants, comprising organic chemical
compounds occurring in small quantities in environmental samples, mostly in µg/L or
ng/L. Among these substances, various medicines, cosmetics, disinfectants and even their
metabolites are included. These compounds have been found in different water envi-
ronments, such as wastewater, surface water, groundwater and tap water [5–8]. Their
presence in the environment mostly results from excretion of compounds by organisms
and the passing of these compounds into wastewater. Yet, they may also derive from
improper disposal of expired pharmaceutical drugs and cleaning supplies [9]. Advanced
treatment technologies and attenuation methods are currently tested against organic micro-
contaminants occurring in sewage and water, e.g., ozonation, nanofiltration and reverse
osmosis [10–16]. Unfortunately, these are not always effective when it comes to removal of
PPCPs, as their efficiencies often vary depending on the compounds involved and their
chemical properties [17,18]. Therefore, slowly degradable contaminants enter the natural
environment and migrate to water bodies, including those which serve as drinking water
supplies. In this regard, PPCPs may pose a threat to aquatic organisms and may be ingested
by humans in tap water [7,19].
Water 2021, 13, 2283. https://doi.org/10.3390/w13162283 https://www.mdpi.com/journal/water
Water 2021, 13, 2283 2 of 30
According to current Polish legislation, the monitoring of pharmaceutical and cosmetic
residues in water is not obligatory. This concerns all types of water samples [20]. Limit
values have not been set for drinking water either [21]. The Polish regulation regarding the
list of priority substances (in force from 2019) [22] includes chemical compounds that may
cause toxicity to organisms and accumulate in ecosystems. Thus, efforts must be made
to prevent large quantities of these pollutants from entering the water environment. This
list contains substances such as pesticides, polycyclic aromatic hydrocarbons and heavy
metal compounds, among other things. Unfortunately, PPCPs are not addressed, even
though the toxicity of some compounds within this group has been confirmed in previous
studies [23–27].
Although the monitoring of PPCPs in water bodies is not mandatory, pilot surveys
have been implemented in some countries to examine water quality and contamination
with pharmaceutical and cosmetic residues [7,28–32]. Positive results from PPCP analyses
have led to greater interest in the problem of water pollution by such compounds. This
issue has also been raised at EU level, and the European Commission (EC) has released the
European Union Strategic Approach to Pharmaceuticals in the Environment. In its commu-
nication from 2019 [33], the EC pointed to a severe problem involving pollution caused by
certain drugs, and it highlighted the need to prevent the adverse effects of pharmacological
substances on the natural environment. Furthermore, in 2020, a watch list of substances
for Union-wide monitoring in the field of water policy was amended [34]. Currently, the
list includes several pharmacological substances to be monitored, e.g., antibiotics, antifun-
gal agents, veterinary drugs and one antidepressant, along with its metabolite. Despite
this, PPCPs are still not included in regular monitoring in Poland. Furthermore, these
contaminants have not yet been adequately addressed in other European countries [35,36].
In addition, in the recent proposal for a Directive of the European Parliament and of the
Council on the quality of water intended for human consumption [37], new parameters
were proposed and recommended for inclusion by the WHO (World Health Organization),
including, among others, three substances classified as endocrine-disrupting compounds
(EDCs): beta-oestradiol, nonylphenol and bisphenol A. In light of the above, it may be
assumed that the monitoring strategies of EU countries and the scope of analysis of water
samples will be extended in the future.
Many recent reviews have focused on the presence of PPCPs in water, on both a world-
wide and a regional scale [1,3,8,38–41]. However, to the best of the authors’ knowledge, to
this day, such research has not been conducted for Poland. This paper presents a compre-
hensive review of research into conditions in Poland in terms of the presence of PPCPs in
the water environment. It summarizes research conducted to date, in Poland, involving
different environmental samples: raw and treated wastewater, landfill leachate, surface
water (standing water bodies and flowing streams), seawater, groundwater and drinking
water. It also briefly outlines possible sources, pathways and release mechanisms of these
microcontaminants in the water environment. This paper presents the most common PPCP
groups detected in water samples and ranges of concentrations for analysed compounds.
An attempt has also been made to outline the overall scale of water contamination with
PPCPs in Poland and to identify the gaps in current knowledge.
2. Sources and Fate of PPCPs in the Water Environment
Most compounds belonging to PPCP groups are derived from anthropogenic sources,
except for some hormones and metabolites, which may have a natural origin [42]. There
are numerous sources and pathways for these microcontaminants in the environment,
which may lead to drinking water contamination (Figure 1). PPCPs are released into the
environment due to human activities in different sectors of industry and urban life. As the
considered substances are residues of medicines and personal care products, their major
sources include pharmaceutical and chemical industries, households, hospitals, landfills,
animal farming and veterinary clinics. Given the mentioned sources, contaminants enter
water bodies primarily through wastewater discharges. This relates to both raw and treated
Water 2021, 13, 2283 3 of 30
wastewater from wastewater treatment plants (WWTPs), because many of the treatment
methods that are currently applied are ineffective in removing organic micropollutants.
Therefore, microcontaminants are transported with treated wastewater from WWTPs to
recipients, mostly rivers and streams [43,44]. Regarding raw sewage, PPCPs may be
released into water or soil by leaky septic tanks, sewage pipelines or even illegal spilling in
rural areas [45,46].
Figure 1. Possible sources and pathways of PPCPs in the natural environment.
Municipal and hospital sewage may carry a significant load of pharmaceuticals and
their metabolites from urine, faeces and expired drugs, disposed via sinks and toilets, which
then find their way into wastewater and WWTPs [47,48]. Some residues from expired
medications are deposited along with domestic waste in municipal landfills, where harmful
compounds are rinsed from waste by rainwater, passing to leachates, and then, through
infiltration or run-off, to groundwater or surface water. Apart from municipal landfills,
industrial waste lagoons are also related to potential sources of PPCPs, especially those
associated with chemical and pharmaceutical industries [18,49,50]. This problem mainly
concerns landfills without base sealing and illegal dumps [17,49]. Regarding landfills
with base sealing, leachate is collected by a leachate drainage system and then directed
to WWTPs.
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It is noteworthy that pharmaceutical residues also include veterinary products, which
occur in wastewater from veterinary clinics. Yet, they may also enter the environment
through aquaculture, agricultural activity and animal farming (including concentrated ani-
mal feeding operations; CAFOs). Veterinary antibiotics, hormones and growth promoters
present in manure are often spread on farmlands as fertilizers. Along with sewage sludge,
which is also used for soil fertilization and may contain accumulated PPCP residues,
they are the cause why agricultural activities are an additional source of these micro-
contaminants, which migrate to soil and groundwater or reach surface water due to the
run-off [17,42,47,51–53]. Interestingly, PPCPs may also be released after the death of an
organism, from its decaying remains. Thus, cemeteries and burial sites are taken into
account as sources of medicine residues as well [14].
In the group of personal care products, various cosmetics and detergents are included:
shampoos, toothpaste, sprays, dyes, perfumes, deodorants, sunscreens, soaps, washing
powders, etc. Since they are applied to skin and on external surfaces, they may pass not
only to wastewater but also directly to surface water as a result of tourist activities in
summer. These substances can be washed from the skin as residues of lotions and other
cosmetics or released into water along with human saliva, sweat and body fluids [54–56].
This also concerns seawater, which may receive additional quantities of PPCPs along with
contaminated rivers [57].
It should be noted that compounds qualified as endocrine-disrupting chemicals (EDCs)
are also regarded as PPCPs, even though, strictly speaking, they might be of industrial
origin, e.g., those used as additives in the production of plastic, dyes, rubber, paper, pack-
ages, etc. Thus, industrial sewage and operations other than chemical and pharmaceutical
industries may be responsible for PPCP contamination to some extent [58–61]. Moreover,
some compounds are emitted into the atmosphere during industrial processes. Subse-
quently, they reach the surface through precipitation and contaminate surface water and
shallow groundwater [62]. Due to hydraulic connection, surface water infiltration may
influence groundwater quality, and thus PPCPs migrate to aquifers. This has been ob-
served, for instance, in the vicinity of riverbank filtration sites [63]. Conversely, if PPCP
pollution sources, such as unsealed landfills or leaky septic tanks, are situated within zones
of groundwater discharge to rivers, then flow direction and migration of compounds are
inverse, and surface water may be contaminated by groundwater.
As mentioned above, PPCPs originate primarily from anthropogenic sources. How-
ever, when present in water, they undergo numerous natural processes, which lead to
their transformation, degradation or subsequent migration. The most important are pho-
tolysis, biodegradation, chemical transformations, hydrolysis, volatilization, sorption of
contaminants on fine particles or organic matter, and dilution resulting from hydrodynamic
dispersion and mixing with clean water or rainwater [14,64]. Their rates are conditioned
by many factors, including the presence and activity of microorganisms, redox potential,
oxygen content, depth, water temperature, pH and other physicochemical properties of
water and soil [65]. All these processes partially result in natural attenuation and reduction
of PPCP concentrations in water. Nevertheless, due to incomplete degradation of PPCPs un-
der natural conditions and low effectiveness of treatment methods for PPCP removal, these
microcontaminants may still appear in drinking water provided by waterworks [25,47].
3. Selection of Materials for the Review
In order to compile information on PPCPs in the water environment of Poland, scien-
tific publications were searched via Google Scholar and ResearchGate, using the following
keywords: pharmaceuticals and personal care products, PPCP, emerging contaminants,
EC and microcontaminants. Since the number of related studies was limited, all research
conducted in Poland was considered, regardless of publication date. Apart from scientific
works such as papers, chapters in monographs and PhD theses, related project materi-
als and legal acts were studied so that we could get acquainted with current trends and
legislation in this field.
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In total, 153 works related to PPCPs were identified. The extent of environmental
contamination with PPCPs was our main interest, and only information on PPCP concen-
trations in real water samples was taken into account. During screening of the gathered
materials, 42 works were excluded since they reported results for synthetic solutions in
laboratory experiments. Of the remaining 111 publications and documents dealing with
the general problem of PPCPs in water or legislation issues, 51 contained specific data
on concentrations revealed during Polish research involving at least one type of water
sample: raw and treated wastewater, landfill leachate, surface water, seawater, ground-
water and drinking water. As most of the publications were not supplemented with raw
databases, information such as sampling sites, type of water sample, analysed compounds
and concentrations were extracted from the published texts.
4. Short Overview of PPCP Groups
A significant proportion of PPCP compounds constitutes of medicine residues. There
are numerous groups of pharmaceutical substances used in the treatment of various dis-
eases. According to the Central Statistical Office [66], over 70% of the Polish population
takes pharmaceuticals, and this has remained constant in recent years. Almost half of all
Poles use over-the-counter (OTC) medicines, including nonsteroidal anti-inflammatory
drugs (NSAIDs) and some analgesics. Prescription drugs are less prevalent but are taken
regularly, primarily by the elderly. Among these substances, the most commonly pre-
scribed drugs are painkillers, which are taken by approximately 32% of adults. Other
medicated groups of drugs are as follows: antihypertensives (prescribed for 21% of adults),
cholesterol-lowering drugs (10%), drugs for cardiovascular diseases (9%), antidiabetic
drugs (6%), hormones (5%), medicines for gastrointestinal disorders (4%), antibiotics (4%),
antihistamines (3%), hypnotics (3%), anti-asthmatic agents (3%), antidepressants (3%) and
other pharmaceuticals (10%). Furthermore, production of pharmaceutical preparations
in Poland has increased over the past decade (from approximately 2140 million EUR in
2010 to 2315 million EUR in 2019) [67]. This also applies to personal care products, includ-
ing all kinds of cosmetics, fragrances, detergents, and other substances used for hygiene
purposes. As in the case medicaments, consumption of soap, detergents and washing
preparations is higher than in previous years (increasing from approximately 609,000 t in
2017 to 652,000 t in 2019) [67,68]. Unfortunately, this fact may contribute to higher loads of
relevant microcontaminants being released into the natural environment.
The conducted review of Polish research in water contamination from pharmaceuti-
cals and personal care products revealed that studies covered at least 39 different PPCP
groups. Among these, 270 compounds were distinguished in total. However, thanks to
the latest analytical techniques, together with rising interest in PPCP occurrence in the
environment, more emerging contaminants are being discovered in water samples. To date,
the most common groups are antibiotics, NSAIDs, painkillers, stimulants, antidepressants,
antihypertensives, hormones and PPCP metabolites. Nevertheless, some groups with few
representative compounds are also being detected in relatively high concentrations, e.g.,
repellents (DEET, the only repelling substance considered in all studies) and alkylphenols
(the main representative of which is bisphenol A, regarded as particularly dangerous due to
its endocrine-disrupting properties). A summary of the characteristics of all PPCP groups
considered in the reviewed Polish studies is presented in Table 1.
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5. PPCPs in the Water Environment of Poland
The following review of conditions in Poland was based on scientific articles and
dissertations referring to studies of pharmaceuticals and personal care products in dif-
ferent water samples, including wastewater before and after treatment, landfill leachate,
surface water (flowing streams and standing water bodies), seawater, groundwater and
drinking water. Information on the occurrence of PPCPs in Polish water was found in over
50 publications. The first information on PPCP occurrence in environmental samples was
mentioned in a study from 2003, and the latest papers were published at the beginning of
2021. The studies focused mainly on wastewater and rivers (Figure 2). Little research con-
cerned PPCP occurrence in landfill leachate and seawater. In the case of drinking water and
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groundwater (which is an essential source of drinking water in many regions of Poland),
analyses were performed less often, compared with types of samples considered to be
more vulnerable to PPCP residues. Seemingly, water types less likely to be contaminated
are rarely subjected to such analyses because the presence of PPCPs in these samples is
not always apparent. Nevertheless, as this review shows, none of the water types may be
regarded as utterly free from microcontaminants.
Figure 2. Number of publications of Polish research on PPCPs in water for different types of samples
(in the years 2003–2021).
The studies covered a wide range of contaminants from different PPCP groups
(Figure 3). In general, the most frequently analysed groups were non-steroidal anti-
inflammatory drugs (NSAIDs) and antibiotics, with information on their determination
found in 36 and 21 scientific papers, respectively. Other compounds of greater interest
were anti-epileptics, metabolites, stimulants, beta-blockers, hormones and antidepressants.
The other PPCP groups were examined rarely or only occasionally.
Figure 3. Number of publications of Polish research concerning compounds from the considered
PPCP groups.
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In Polish research, two analytical methods have dominated. The most frequently
applied method has been gas chromatography coupled with mass spectrometry (GC-MS)
and, less often, the liquid chromatography–mass spectrometry (LC-MS) method. According
to the studies that we considered, many of the analysed compounds were in concentrations
below the limit of detection (<LOD) or limit of quantification (<LOQ) established during
the research. Such results were reported especially for groundwater, drinking water,
some streams and lakes. Although these outcomes may seem irrelevant, the mere fact of
performing such analyses suggests a growing interest in the problem concerning PPCPs in
this country. Moreover, knowledge about the list of previously analysed substances (and
their presence or absence in the environment) allows us to focus on the substances (and
water bodies) which pose the greatest issue in terms of pollution levels. Apart from <LOD
and <LOQ results, in several cases, only the fact of detection of PPCPs was mentioned,
without any indication being given of specific values (i.e., above the limit of detection,
>LOD). The other results were diversified in terms of concentrations, depending on the
particular compound and the type of water sample.
The number of PPCP groups taken into account in the reviewed studies was found to
be similar for wastewater, surface water, groundwater and drinking water (Table 2). This
number was significantly lower for landfill leachate and seawater. However, the number
of compounds analysed for each of these groups varied considerably, and some groups
contained only one or two substances. Hence, our comparison does not specifically indicate
the scale of the problem associated with PPCP contamination. However, it does provide an
insight into the general trend in current Polish research focusing on PPCP occurrence in
the water environment.
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IN TOTAL 28 28 9 36 5 33 27
The current situation with regard to water environment contamination with PPCPs in
Poland is summarized for the above-mentioned types of water samples (raw wastewater,
treated wastewater, landfill leachate, surface water, seawater, groundwater and drinking
water) in the following sections. We have made an effort to present the most important
outcomes achieved in the reviewed research, highlighting compounds and water types
characterized by the highest concentrations and level of contamination with PPCPs. All
the detailed results found in the studied literature are included in the Supplementary
Material (Table S1). It should be noted that many of the results are single values and the
sole information on PPCP concentrations in a given water sample. Unfortunately, the
analysed literature frequently did not provide meaningful information concerning, for
example, the exact location of sampling points. As for works on wastewater samples before
and after treatment, more often than not, there was a lack of details on applied treatment
technologies and their stages. Therefore, it was impossible to assess the treatment efficiency
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or attenuation rate for these compounds in natural conditions. Moreover, the limited
number of results did not allow us to perform a statistical analysis, and we only took
into account ranges of reported PPCP concentrations (minimum and maximum values).
Hence, the outcomes from this review provide only an overall view of the level of water
contamination from PPCPs in Poland. Despite this, the review did identify gaps in current
knowledge and revealed key water types and substances, which could become interesting
subjects for future research.
5.1. Raw Wastewater
After surface water, wastewater was the second most studied water environment in
Poland in terms of PPCPs. Study results relating to the presence of these compounds in
untreated wastewater were found in 21 publications and included 136 compounds, mainly
metabolites (23), antibiotics (22), nonsteroidal anti-inflammatory drugs (11), stimulants
(11) and painkillers (9). The authors of the publications did not always report in detail the
number and location of wastewater treatment plants from which the wastewater samples
were collected for analysis; therefore, it is not possible to present detailed data on the
sources of wastewater samples analysed in Poland. The full list of PPCPs investigated in
untreated wastewater is provided in Table S1. Here, only the most interesting findings
are described.
The most frequently tested PPCPs in raw wastewater in Poland were non-steroidal
anti-inflammatory drugs [17,44,50,71,73,76,78,82–87]. The maximum concentration of
naproxen (551,960 ng/L) turned out to be the highest among all the PPCPs analysed.
Four other compounds from this group were found in high concentrations as well: ketopro-
fen (up to 233,630 ng/L), diclofenac (up to 40,570.2 ng/L), ibuprofen (up to 31,250 ng/L),
and flurbiprofen (up to 4952 ng/L). As many as 22 compounds belonging to the antibiotic
group were found in raw wastewater [17,71–73,76,88]. The highest concentrations were
found for metronidazole (7400 ng/L), but five other compounds were also found with their
maximum concentrations exceeding 1000 ng/L: ciprofloxacin, vancomycin, sulfamethox-
azole, sulfasalazine and clarithromycin. Of the nine painkillers analysed, paracetamol
was the most frequently tested in raw wastewater. Its concentration ranged from <LOD
to 51,400 ng/L [73,79,83,86,87]. Pentoxifylline [76], codeine, morphine, methadone and
ketamine were also found [71]. Among 11 investigated stimulants, the most frequently
studied was caffeine, with concentrations reaching 89,544.5 ng/L [17,71,73,76]. Even higher
concentrations were found in the case of nicotine, from 19,035 ng/L to 423,978 ng/L [71].
The other stimulants detected were amphetamine, cocaine, MDMA (midomafetamine),
PMA (para-Methoxyamphetamine) and mephedrone [71].
Metabolites, degradation products of other compounds, represent the largest group
of compounds (23) studied in untreated wastewater. Most metabolites were analysed in
one project [71]. Compounds detected in the highest concentrations included paraxan-
thine [71], salicylic acid [73,84,87], ibuprofen-2-hydroxy [76], cotinine [71], and N-acetyl-
sulfamethoxazole [88].
Among the other PPCPs investigated in raw wastewater in Poland, high concen-
trations were detected for metformin (up to 16,790.7 ng/L) (representing anti-diabetic
drugs) [73], atorvastatin (up to 2756.5 ng/L) (representing lipid-modifying agents) [71], val-
sartan (up to 92,532.7 ng/L), irbesartan (up to 3142.3 ng/L) and losartan (up to 1708.8 ng/L)
(a form of antihypertensive medication) [71,73] or, in the case of diuretics, furosemide (up to
3372.5 ng/L) and hydrochlorothiazide (up to 5072.3 ng/L) [73,82]. Of the seven hormones
investigated in untreated wastewater in Poland, three were not detected in any sample
(oestriol, 17α-ethynyloestradiol and diethylstilboestrol) [50,87], while the rest was found
in various concentrations: levonorgestrel (up to 1529.8 ng/L) [73], 17β-oestradiol (max.
1067.8 ng/L) [17,50,71,87], oestrone (max. 773.3 ng/L) [14,50,71,87] and progesterone (up
to 89.3 ng/L) [73].
Relatively high concentrations of cosmetic and pharmaceutical preservatives were
found in raw wastewater, with the highest values detected for methylparaben (max.
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40,898.6 ng/L) [50,71]. High concentrations were also found for another group of com-
pounds, alkylphenols [50,69,71,78,85,89,90]. In this group, bisphenol A (up to 12,060 ng/L)
and nonylphenol (up to 102,540 ng/L) were found at the highest concentration. One
study of raw wastewater in Poland included two UV filters, benzophenone and 3-(4-
methylbenzylidene)camphor, as well as the commonly used repellent DEET [50]. Apart
from these, carbamazepine (up to 3217.1 ng/L) was a relatively frequently tested PPCP, a
form of anti-epileptic medication [50,73,76,84,89].
5.2. Treated Wastewater
The results of PPCP studies of treated wastewater in Poland were published in 24 pub-
lications. The compounds tested in treated wastewater were almost the same as those tested
in untreated water. In total, 127 PPCP compounds were analysed in treated wastewater. In
general, significantly lower concentrations of studied PPCPs were observed in comparison
with untreated wastewater. Only a few substances were present at similar levels, and even
more rarely, higher concentrations were observed in comparison with raw wastewater. The
last case was found to relate almost exclusively to metabolites and may also have resulted
from the limited number of samples tested and from the fact that sampling procedures did
not include sampling of the same wastewater before and after treatment processes. As a
result, the wastewater samples were collected at random, and the results do not represent
the effectiveness of wastewater treatment.
The most commonly investigated PPCPs were non-steroidal anti-inflammatory
drugs [17,44,71,73,75,78,79,82–87,91–93]. The highest concentrations were detected in the
case of ibuprofen (up to 22,610 ng/L), but elevated values were also found for naproxen,
diclofenac and ketoprofen. As many as 21 antibiotics were tested in treated wastewater in
Poland [71–73,88], but most of these were tested only once per study. The highest concentra-
tions were found for sulfamethoxazole (508–770 ng/L). The presence of nine painkillers was
also studied in treated wastewater [71,73,75,83,86,87,91], and paracetamol was found in
the highest concentrations (max. 3824 ng/L). The other compounds, metamizole, codeine,
morphine, methadone and ketamine, were found in much lower concentrations.
A fairly frequently tested PPCP group was that of alkylphenols [50,71,78,85,89,90,93],
with bisphenol A reaching the highest concentration (up to 10,840 ng/L). Among cosmetic
and pharmaceutical preservatives, the most commonly investigated was methylparaben
(max. 1440 ng/L). Benzophenone (representing UV filters) was found to have a maximum
concentration of 1400 ng/L [50], and DEET was found in the range of <LOD–1150 ng/L [50].
The studies indicated that some stimulants were found in treated wastewater but at
much lower concentrations, compared with raw wastewater. The highest concentrations
were observed for caffeine (up to 2868.5 ng/L) and nicotine (up to 2222.5 ng/L), while
no evidence of amphetamine, methamphetamine, MDA (tenamfetamine), MDEA (3,4-
Metylenodioksy-N-etyloamfetamina), mCCP (metachlorophenylpiperazine) or MDPV
(3,4-Metylenodioksypirowaleron) was found [17,71,73,94].
Among the 19 investigated metabolites in treated wastewater [50,71,73,75,84,87,88,91,92],
the highest concentrations were detected for paraxanthine (up to 1881.3 ng/L). High concen-
trations in treated wastewater were observed also for carbamazepine (max.
5127.8 ng/L) [50,73,75,84,89,91], venlafaxine and diazepam (antidepressants) [17,71,95].
Metformin (an anti-diabetic drug) was found in low concentrations (max. 62.9 ng/L) [73],
as well as trimetazidine (an anti-ischemic agent, up to 457.8 ng/L) [73].
It is also important to mention that four compounds from the antihypertensives group
have been found in treated wastewater investigated to date: valsartan, irbesartan, losartan and
ramipril [71,73]. High concentrations were found for two compounds representing diuretics:
hydrochlorothiazide (up to 4313.7 ng/L) and furosemide (up to 1879.2 ng/L) [73,82].
Of the seven hormones tested, four were not found in treated wastewater, and the
remaining three were detected in low concentrations: 17β-oestradiol (<LOD–432 ng/L),
oestrone (<LOD–249 ng/L), and progesterone (9.4–13.4 ng/L) [17,50,71,73,87]. Numerous
studies [50,71,78,84,85] reported evidence of one antibacterial agent (triclosan), found at
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low concentrations (up to 910 ng/L). Studies of wastewater treated in Gdańsk [73] and
Cracow [71] revealed presence of two compounds belonging to the group of antihistamines
and histamine receptor modulators: ranitidine and fexofenadine. From the beta-blockers
group, metoprolol and atenolol were found [17,75,84,91]. Only two compounds belonging
to fibrates were detected: bezafibrate and clofibric acid [44,71,84,96]. Thiabendazole (an an-
tifungal agent) was tested only twice, and the results showed slightly higher concentrations
compared with raw wastewater [72].
Three PPCP groups analysed in treated wastewater were not detected at all: alpha1-
blockers [75,91], corticosteroids [75,91] and PDE5 inhibitors [71].
5.3. Landfill Leachate
To date, landfill leachate in Poland has been studied only rarely in comparison with
wastewater. Nevertheless, landfill leachate is also considered to be wastewater, which
may strongly influence the quality of the water environment. It particularly concerns
groundwater in the vicinity of both industrial and municipal dumps without base sealing,
where leachate may infiltrate shallow aquifers along with microcontaminants. Although
there have been few results for PPCP occurrence in leachate in Poland, they have confirmed
the presence and high concentrations of some PPCPs in such samples.
Landfill leachate studies revealed the presence of nine PPCP groups: alkylphenols,
antibacterial agents, antiepileptics, cosmetic and pharmaceutical preservatives, hormones,
metabolites, NSAIDs, repellents and UV filters. In total, these included 16 compounds
reported in three publications between 2016 and 2019. Almost all the results showed
concentration values above the detection limit. The published results mainly referred to
landfills located in north-eastern Poland. The most common group was cosmetic and phar-
maceutical preservatives (4 compounds), among which methylparaben dominated (up to
17,150 ng/L). However, in this area, the maximum PPCP concentrations in landfill leachate
were found for other compounds, e.g., DEET (up to 202,420 ng/L) and diclofenac (up to
108,340 ng/L) [49,50]. The remaining analysed PPCPs occurred in lower amounts, e.g., UV
filters (benzophenone and 3-(4-methylbenzylidene)camphor, whose concentrations reached
up to 16,640 ng/L) and metabolites (4-n-octylphenol and 4-n-nonylphenol). Concentra-
tions of diethylstilboestrol, 17β-oestradiol, oestrone and triclosan were at a moderate level.
Trace amounts of carbamazepine from the antiepileptics group were also expected [49,50].
Interestingly, another study (conducted in north-eastern Poland) found bisphenol A in
leachate in considerable amounts, reaching 2,202,000 ng/L [69].
5.4. Surface Water
Among natural water sources in Poland, surface water bodies have been relatively well
researched, and almost all the considered PPCP groups (36) have been investigated. This
especially applies in the case of flowing streams, with information on PPCP concentrations
found for 39 rivers, including the longest ones, such as the Vistula, Odra and Warta. In
the case of standing water bodies, six lakes and artificial reservoirs were studied. In total,
the results were presented in 29 publications. The studies related to over 220 compounds,
the majority of which were antibiotics. The performed analyses often indicated a lack
or trace amounts of PPCPs in surface water (<LOD or <LOQ). Concentrations of some
PPCPs were considerably higher, which pointed to a link between sewage discharge from
WWTPs and the level of water pollution in surrounding areas. Their quality and the
amount of microcontaminants influence other water bodies, for instance, groundwater
through surface-water infiltration and aquifer recharge, and seawater, through river inflow
to the sea, along with PPCP loads. Based on this, studies of rivers and streams may
reflect, to some extent, the overall state of the entire water environment in terms of PPCP
contamination.
With regard to antibiotics, 73 substances were analysed in all the considered research,
and this formed the most common PPCP group. In most cases, concentrations did not
exceed detection or quantification limits. Some studies revealed presence of antibiotics
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up to several dozens of ng/L, e.g., lincomycin, sulfadimethoxine, ofloxacin, sulfapyridine,
amoxicillin, carbadox and sulfasalazine [71,74,80,97,98]. Some substances occurred in
concentrations of several hundreds of ng/L, e.g., sulfathiazole, metronidazole, clindamycin,
sulfamethoxazole, azithromycin and ciprofloxacin [72,74,99]. The highest concentration of
antibiotics exceeded 1000 ng/L but only in the case of the Vistula River [74]. This applied to
antibiotics such as sulfamethoxazole (with the highest concentration, reaching 1770 ng/L),
azithromycin, clarithromycin, ceftazidime and erythromycin. According to this review, the
main river in Poland seems to be more contaminated with antibiotics compared with other,
smaller streams, also tested for the presence of PPCPs [81,97,100,101].
Another group often analysed in surface water has been that of NSAIDs, with 15 sub-
stances having been tested to date. Contrary to antibiotics, NSAIDs were found to occur
not only in major Polish rivers but also in smaller streams and standing water bodies. For
instance, up to 3730.1 ng/L of ibuprofen was found (one of the most popular drugs in
this group) [71,86]. NSAIDs in concentrations above 1000 ng/L also included diclofenac
and naproxen [44,71,91,102]. The remaining non-steroidal anti-inflammatory drugs were
detected in lower concentrations, e.g., acetylsalicylic acid, diflunisal, fenoprofen, ketorolac
and indomethacin [43,63,71,75,80,82,87,101–105].
Other PPCP groups were studied less often, and lower concentrations of compounds
were observed. However, quantities of several substances in surface water were relatively
high, even comparable with treated wastewater; for example, beta-blockers, i.e., bisoprolol,
sotalol and metoprolol, were found in concentrations of up to 2190 ng/L [70]. Similar results
were reported for painkillers, such as tramadol and metamizole [75,98]. The most popular
painkiller, paracetamol, occurred in lower quantities (up to 337.7 ng/L) [86]. This group
also included opiates, e.g., codeine and morphine. Interestingly, they were found in smaller
streams, but their concentrations were lower compared with other painkillers [71]. In longer
rivers, such as the Vistula, other PPCP groups were abundant, e.g., antihypertensives
(especially irbesartan, with concentrations of up to 6558.8 ng/L) and diuretics [70,71].
Among anti-epileptics, carbamazepine (794 ng/L) was dominant [81,98]. In the case of
antidepressants, desvenlafaxine and venlafaxine stood out from the compounds within
this group.
Hormones were detected frequently (9 compounds) [51,71,80,87,105]. Their levels in sur-
face water did not exceed 100 ng/L and ranged from <LOD to 84.15 ng/L (diethylstilbestrol).
Similar results were reported for stimulants and fibrates, with the exception of caffeine (found
at a high concentration of 29,995.5 ng/L), nicotine and clofibric acid [55,70,71,80]. Regard-
ing alkylphenols, contrast agents and corrosion inhibitors, among these groups, bisphenol
A occurred in the highest concentration (3113 ng/L) [63,81,90,99,106]. Among personal
care product residues (such as cosmetic and pharmaceutical preservatives, UV filters
and repellents), interesting results were found for methylparaben, ethylparaben, propyl-
paraben and DEET [71,80]. Within the remaining PPCP groups, one or a few substances
were examined. Their concentrations ranged from <LOD or <LOQ to several hundreds
of ng/L, and they were mostly detected in the main Polish rivers, i.e., the Vistula and
Warta. These involved groups such as antiarrhythmics, antiretroviral and antidiabetic
drugs, hypnotics, PDE5 inhibitors, lipid-modifying agents, sugar substitutes, antiparasitic,
antibacterial and antifungal agents, antihistamine and histamine receptor modulators,
and immunosuppressive drugs. Examples of contaminants from the above-mentioned
groups are fluconazole, darunavir, mycophenolic acid, triclosan and saccharin [74,81]. In
smaller streams, substances detected in higher concentrations included fexofenadine and
temazepam [71,72,77,80,95,100].
Moreover, in the Polish research we studied, 20 metabolites were taken into account.
Most of these were not detected (<LOD) or were found at a low level, except for several
compounds, e.g., paraxanthine (caffeine metabolite, with the highest concentration in this
PPCP group, reaching 90,665 ng/L), oxazepam (diazepam metabolite), cotinine (nicotine
metabolite) and oxypurinol (allopurinol metabolite) [71,81]. For several PPCP groups, the
Water 2021, 13, 2283 18 of 30
pharmaceuticals were determined in some Polish rivers. However, all the results were
below the detection or quantification limits [70,92,94,98,100,105].
5.5. Seawater
In this review, seawater was analysed separately from other surface water resources
due to its specificity and distinct conditions, different from freshwater. Poland has access
to the Baltic Sea, and thus all the results concern only this water body. For seawater, low
PPCP concentrations are generally assumed because of their dilution in large amounts of
water. However, inflowing polluted streams and tourist activity by the seaside in summer
may result in the presence of some contaminants in seawater.
Research on seawater confirmed the presence of substances from five PPCP groups
(antibiotics, antiepileptics, NSAIDs, painkillers and stimulants). These included 23 com-
pounds many of which were found in concentrations higher than the limit of detection.
Research results published in 5 scientific articles referred to determination of PPCPs in
the southern Baltic Sea along the Polish border, and the remaining ones concerned only
the Gulf of Gdańsk and Bay of Puck in the Gdańsk region. The PPCPs qualified as an-
tibiotics (13 compounds) and NSAIDs (8 compounds) had the greatest representation
among the PPCP groups [102,107]. Among these groups, oxolinic acid and ketoprofen
dominated (up to 1026 ng/L and 616 ng/L, respectively) [83,108]. Detected substances
with lower concentrations from other PPCP groups were paracetamol, carbamazepine and
caffeine [83,101].
5.6. Groundwater
Groundwater bodies in Poland were studied less frequently compared with surface
water in terms of PPCP occurrence. Apparently, these are associated with a lower risk of
significant pollution and a lower possibility of high concentrations of microcontaminants
since wastewater is directed mainly into streams and does not usually affect aquifers
directly. Even in riverbank filtration sites, along the flow path and where there is mi-
gration to shallow aquifers, pollutants undergo various natural processes that lead to
self-attenuation. Therefore, levels of PPCPs in groundwater are generally lower than on
the surface. Nevertheless, aquifers are an essential source of drinking water in Poland,
and thus great emphasis is placed on the protection of groundwater reservoirs. Locally,
aquifers may be more vulnerable to pollution, which can be observed in the vicinity of
municipal or industrial landfills. In such places, PPCP concentrations may be considerably
higher due to constant and large loads discharged to aquifers and specific conditions
occurring in the groundwater environment, which often influence the low degradation
rate of some contaminants. The problem of groundwater contamination was noticed, as (in
2017) complex screening studies of PPCPs in groundwater were performed for the whole
Poland (carried out for 93 sampling points, by the Polish Geological Institute National
Research Institute) [28]. Apart from this, the rest of the studies were incidental and limited
to a specific location.
The occurrence of PPCPs in Polish groundwater bodies has been investigated in
14 scientific papers to date. Most of the results have been published only recently, which
suggests a growing interest in the problem of groundwater contamination with compounds
qualified as PPCPs, and more studies may be expected in the future. In the research
considered in this review, 122 compounds from 33 PPCP groups were analysed in total,
although the vast majority were found at levels below the detection or quantification limits.
So far, antibiotics constitute the most studied PPCP group in Polish research (with 19
compounds). The highest concentration was reported for sulfapyridine (177.1 ng/L)
and sulfamethoxazole (66 ng/L) [28,101,109]. The remaining antibiotics occurred in
lower quantities [28,73,109]. Most studies on PPCP performed, published in 11 articles,
were about NSAIDs. Pharmaceuticals included in these analyses were, among others,
diclofenac (with the highest concentrations, reaching 2770 ng/L), ibuprofen, ketopro-
fen and naproxen [28,50,63,73,99,105,109,110]. NSAID concentrations were higher com-
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pared with other medicines used for similar purposes, i.e., painkillers such as parac-
etamol (up to 113.1 ng/L) [73,81]. Another interesting compound is carbamazepine,
found in concentrations of up to 869 ng/L, and this was the most abundant drug among
anti-epileptics [28,81,109]. A similar maximum concentration was reported for caffeine
(873.3 ng/L) [101].
Hormones were also taken into consideration in research into groundwater quality.
Among eight studied substances, the highest concentrations were detected for estrone (up
to 309 ng/L), and 17α-ethynyloestradiol (61 ng/L) [28,109,111]. For the other hormones,
the results were mostly below or very close to the quantification limit [28,49,73,105,109,110].
Another fairly frequently analysed group is that of beta-blockers but only sotalol and atenolol
concentrations exceeded the quantification limits [73,81]. Similar outcomes were revealed for
antidepressants, among which only fluvoxamine was detected [28,73,81,95,109,110].
Some personal care products (i.e., cosmetic and pharmaceutical preservatives, UV filters
and repellents) were quantified only in north-eastern Poland, in the aquifer extending within
municipal landfills [49,50,111]. This was found to mainly apply to DEET, whose concentra-
tions reached 17,280 ng/L. In this region, large quantities were also reported for bisphenol
A (an alkylphenol), 3-(4-methylbenzylidene)camphor and methylparaben [49,50,106,111].
The other PPCPs detected in Polish groundwater belong to such groups as antibacterial,
antifungal and chemotherapeutic agents, antidiabetic drugs, antihistamines and histamine
receptor modulators, antihypertensives, antiischemic agents, contrast agents, corrosion
inhibitors, diuretics, sugar substitutes and vasodilators [50,63,73,81]. In the case of com-
pounds qualified as alpha-1 blockers, beta2-adrenergic antagonists, antiarrhythmic drugs,
antidementia drugs, antiparasitics, antithrombotics, fibrates and lipid-modifying agents,
these were analysed in Polish groundwater, but all the results were below the detection
or quantification limits [28,73,81,105,109,110]. Furthermore, PPCP metabolites were taken
into account only in several studies. Interestingly, oxypurinol definitely stood out from
these substances, as it appeared in concentrations of up to 1350 ng/L [81].
5.7. Drinking Water
In Poland, drinking water is derived from either groundwater or surface water sup-
plies. In the case of both water sources, Polish research confirmed the presence of some
PPCPs. Undoubtedly, prior to distribution by waterworks, water intended for consumption
is treated at water treatment plants (WTPs) using various treatment technologies. Nonethe-
less, even the most advanced methods do not always remove PPCP contamination. Hence,
some slowly degradable substances may occasionally be found in tap water, although their
concentrations are generally at trace levels. In this review, all results for drinking water
related to samples taken and analysed after treatment in WTPs.
National research indicated that 27 PPCP groups were analysed in drinking water.
These included 95 compounds, some of which had concentrations higher than the limit
of detection. The presence of PPCP groups in drinking water in large Polish cities was
reported in 10 articles [70,73,74,77,82,95,102,105,106]. The published results mainly re-
ferred to research in Warsaw, Gdańsk and Poznań. The most common were antibiotics
(27 compounds). Fewer substances represented other PPCP groups: antihypertensives
(10 compounds), NSAIDs and beta-blockers (8 compounds each) as well as fibrates and
hormones (5 compounds each). The remaining PPCP groups included mostly one or
two substances. The maximum concentrations in drinking water investigated in Poland
were observed in the case of ibuprofen (up to 224 ng/L), azithromycin (193 ng/L), parac-
etamol (173 ng/L) and caffeine (159 ng/L). Concentrations of one order of magnitude
lower were reported for erythromycin, clarithromycin, telmisartan, valsartan, furosemide,
hydrochlorothiazide, levonorgestrel and bisphenol A. In drinking water, there were only
trace amounts in the case of compounds from PPCP groups such as beta2-adrenergic
agonists, antidepressants, lipid-modifying agents, antiparasitics, chemotherapeutic agents
and immunosuppressive drugs.
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6. Discussion
This review has shown that PPCP determination in water samples in Poland is per-
formed more and more frequently. Yet, the number of analyses still seems to be relatively
low, particularly in the case of landfill leachate and seawater, which makes a results com-
parison unfeasible. Similarly, it was not possible to assess wastewater or drinking water
treatment efficiencies based on the published data as the results tended to depict one-shot
and non-time-shifted sampling, and hence a comparison of these results would have been
inaccurate. The collected data have only facilitated a general summary of PPCP occurrence
(and variations in concentrations) in different types of water samples.
Undoubtedly, the most studied PPCP groups were antibiotics and NSAIDs. Antibiotics
appeared in raw wastewater in concentrations reaching several thousands of ng/L. Apart
from a few exceptions (e.g., azithromycin and clindamycin), antibiotics were usually found
in smaller quantities in wastewater after treatment processes, decreasing mostly by one or
two orders of magnitude (Figure 4). A similar pattern can be seen in the case of triclosan,
whose antibacterial properties are used in cosmetics and detergents. As mentioned earlier,
this cannot be compared in terms of treatment efficacy, but the results revealed that some
compounds might be more resistant, so the quantities found in treated wastewater are
comparable to those in samples before treatment. However, it should be noted that the
efficacy depends on both compound properties and the treatment methods used.
Figure 4. Variations in maximum concentrations of selected antibiotics and one of the antibacterial agents in different water
sample types.
Antibiotics were often present in rivers, and their concentrations did not differ much
from those in treated wastewater (Figure 4). In some cases, the concentration values were
higher than 1000 ng/L and exceeded the highest levels reported for wastewater (e.g.,
erythromycin and clarithromycin). This may suggest that the problem with antibiotics
in water and sewage is even more common, and more studies are required in order to
ascertain the extent of contamination from this pharmaceutical group. Such studies could
also clarify migration of this group to aquifers, as previous studies of groundwater were
only conducted for several locations. According to the gathered data, antibiotics rarely
occur in groundwater, and their concentrations are low. These results might be slightly
misleading, however, as the presence of antibiotics was confirmed in a few studies of
drinking water derived from groundwater supplies. Concentrations reaching dozens
or even hundreds of ng/L (e.g., azithromycin, clarithromycin and erythromycin) would
suggest that even higher amounts are present in source water.
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NSAIDs are not as relevant as antibiotics. However, as representative pharmaceuticals
are over-the-counter drugs, they are the medications taken most often. They are very
common in the water environment, at high concentrations especially in raw wastewater,
sometimes reaching hundreds of thousands of ng/L (e.g., naproxen and ketoprofen). The
reported concentrations in wastewater after treatment were significantly lower (Figure 5),
with the exception of ibuprofen (the most popular NSAID in Poland), whose maximum
concentration in treated wastewater was above 20,000 ng/L. High concentrations of ibupro-
fen were also observed in surface water, which confirms its widespread use. In contrast,
paracetamol, one of the painkillers used for similar purposes (and prescribed as often as
ibuprofen), occurred in smaller amounts in both treated wastewater and rivers. This, in
turn, may suggest lower resistance to applied treatment methods and processes taking
place under natural conditions. NSAIDs and paracetamol are present in groundwater and
drinking water, in some cases reaching levels of hundreds of ng/L (Figure 5).
Figure 5. Variations in maximum concentrations of selected NSAIDs and one of the painkillers in different water sam-
ple types.
To date, it is clear that less attention has been paid to other PPCP groups. Some of
them are important in terms of water contamination due to their dominance among pre-
scription drugs or proven adverse effects on aquatic organisms. One of the most frequently
prescribed drug types is that of pharmaceuticals used in the treatment of cardiovascular
diseases, e.g., antihypertensives, beta-blockers and fibrates. Within these groups, anti-
hypertensives prevailed, and valsartan was found to be a dominating compound, with
concentrations close to 100,000 ng/L in raw wastewater (Figure 6). Valsartan also prevailed
in the drinking water samples studied. This has not been found in groundwater so far,
but it should be emphasized that only one study focused on this compound in an aquifer
within one region. Given its abundance in other water samples, valsartan is also likely to be
present in groundwater. For this type of water body, beta-blockers were determined more
frequently, but in most cases, their concentrations were very low or below the detection
limit. Nevertheless, PPCPs qualified as belonging to the described groups were still present
in treated wastewater and surface water. As with antibiotics, the maximum concentra-
tion values for some PPCPs in rivers were close to or above their level in wastewater
(e.g., irbesartan and metoprolol). This may suggest that the problem associated with their
appearance in the water environment is more acute than previously thought.
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Figure 6. Variations in maximum concentrations of selected antihypertensives, beta-blockers and fibrates in different water
sample types.
As mentioned before, hormones and metabolites are practically the only groups whose
presence in the environment may be associated with natural processes and reactions. How-
ever, the concentrations of compounds representing these two groups vary significantly.
Hormones are regarded as endocrine-disrupting chemicals, negatively affecting living
organisms. This group was generally observed in low concentrations, reaching 1000 ng/L
(except for 17β-oestradiol in one study) (Figure 7). There are scarce data on hormones in
drinking water in Poland, but one Polish study confirmed the occurrence of levonorgestrel
and progesterone in tap water. Since compounds from this group were observed in drink-
ing water supplies such as surface water and groundwater, it may be assumed that future
studies will reveal their presence in tap water taken from other areas in Poland.
Figure 7. Variations in maximum concentrations of selected hormones and metabolites in different water sample types.
There are potentially countless PPCP metabolite substances. To date, studies have
shown that the principal metabolites are those originating from stimulants and OTCs,
e.g., metabolites of caffeine (paraxanthine) and nicotine (cotinine) and acetylsalicylic acid,
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widely known as aspirin. Apart from caffeine, the parent compounds have rarely been
taken into account in the reviewed publications, while their derivatives have been found to
reach dozens or hundreds of ng/L (Figure 7). The collected data allow us to assume that
relatively high levels of these substances are removed from wastewater. Nonetheless, they
seem to be very common in rivers and streams. The probable reason may be that they are
derived from products in widespread use (coffee, tea, cigarettes, OTCs, etc.) and are thus
released more frequently into water. As with hormones, metabolites were the subject of
only a few studies, and their significance currently seems to be underrecognized.
The other PPCPs groups have not been studied as often in Poland. Yet, some individual
compounds have been detected in water samples in significant amounts. Examples of such
PPCPs are presented in Figure 8. Among the remaining groups, caffeine stands out due to
its abundance in all types of water samples. Like its metabolite, paraxanthine, the highest
concentrations were observed in raw wastewater and rivers, and lower values were found
in treated wastewater. Its prevalence in the environment has been confirmed, although
the compound seems to be less resistant to treatment processes in WWTPs. Moreover,
caffeine was also detected in relatively high concentrations in groundwater and drinking
water samples (Figure 8). Other interesting PPCPs found in the review were bisphenol A,
methylparaben and DEET. These stood out in terms of their concentrations in groundwater,
exceeding 1000 ng/L. However, it should be emphasized that these results were obtained
for aquifers next to municipal landfills. Therefore, the concentrations of these substances
in groundwater away from landfills may be lower. Nevertheless, it is interesting to note
that bisphenol A, regarded as an EDC, was found in drinking water samples. In turn, no
information was found in terms of determination of methylparaben and DEET in drinking
water. As these compounds have been found to be present in all other water sample types,
migration of these substances to drinking water supplies cannot be excluded. Furthermore,
there is still little information on EDCs included in the proposal for the Drinking Water
Directive, i.e., bisphenol A, nonylphenol and 17β-oestradiol. In Poland, these have not yet
been analysed in drinking water at all, except for one study, which looked at 17β-oestradiol.
Thus, more attention should be paid to these compounds in future research.
Figure 8. Variations in maximum concentrations of selected PPCPs in different water sample types.
From the other PPCP groups, carbamazepine (an anti-epileptic), one of the most often
studied PPCPs in all water sample types, was found in significant concentrations (e.g.,
in groundwater). Another interesting compound was metformin (an anti-diabetic drug),
which was analysed in a few studies, almost all of which found its concentrations to be
higher than quantification limits. Finally, two diuretics, furosemide and hydrochloroth-
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iazide, were reported in drinking water at concentrations above 20 ng/L, while their
quantities in wastewater were moderate compared with other PPCPs (Figure 8).
Due to limited research performed in Poland to date, the collected data enable only a
general comparison of approximate concentrations in various water environments. Landfill
leachate and seawater have been the subject of fewest studies. Studies have only been
conducted within north-eastern Poland (municipal landfills) and along the Polish coastline
(the Baltic Sea). Only single studies have focused on these types of water samples, and
information on possible PPCP occurrence is minimal (not taken into consideration in the
above-described analysis). However, these results may form the basis for further studies.
In landfill leachate, concentrations of studied PPCPs were found to be very high,
in some cases even greater than in wastewater. The studies focused mainly on personal
care product residues rather than pharmaceuticals. The highest concentrations (above
100,000 ng/L) were reported for DEET, bisphenol A and diclofenac. An interesting fact
is that aquifers close to landfills were impacted significantly, manifested in groundwa-
ter highly contaminated with certain PPCPs, with concentrations even reaching several
thousands of ng/L. This was found for both unsealed and sealed landfills. The review
has shown that landfills may constitute a severe threat to groundwater quality in terms
of PPCPs. For this reason, more attention should be paid to both landfill leachate and
groundwater in the vicinity of dumps in order to more fully understand the possible
migration of PPCPs to aquifers.
Interpretation of data on seawater presented even more of a challenge. Due to spe-
cific conditions, this was studied separately from other surface water resources in the
review. To date, seawater research has focused on the most common PPCP groups, i.e.,
antibiotics, NSAIDs, and several other pharmaceuticals. The results are very diversified,
and PPCP contamination in seawater seems to be a complex issue, with numerous factors
influencing the level of microcontaminants concentrations, including dilution, sampling
depth, seawater-groundwater exchange, additional PPCP loads from smaller streams,
direct sewage discharges to the sea and even tourist activities during the summer season.
Threshold values have yet to be set for PPCPs in drinking water and in water bodies,
and it is not possible to compare PPCP concentrations with existing regulations. However,
in the recent proposal for a Directive of the European Parliament and of the Council on
the quality of water intended for human consumption, the WHO suggested precautionary
benchmark values for 17β-oestradiol, nonylphenol and bisphenol A, as aquatic life is
sensitive to the effects of estrogenic EDCs. For these substances, the proposed values
are 0.001 µg/L (i.e., 1 ng/L), 0.3 µg/L (i.e., 300 ng/L) and 0.01 µg/L (i.e., 10 ng/L),
respectively. To date, there is little information about these substances in drinking water in
Poland. Nonylphenol was not analysed in either drinking water or source water (surface
water and groundwater). Only one study measured 17β-oestradiol in drinking water,
and the hormone was not detected. As 17β-oestradiol, bisphenol A was analysed in only
one study, which revealed that the benchmark value for this compound was occasionally
exceeded. Interestingly, 17β-oestradiol and bisphenol A were found in surface water
and groundwater, which may be used for drinking water supplies. In several cases, the
concentrations of these substances greatly exceeded the proposed benchmark values. For
example, 17β-oestradiol was observed in concentrations of up to 46.15 ng/L in surface
water and up to 48 ng/L in groundwater. Concentrations of bisphenol A were even higher,
reaching 3113 ng/L and 6880 ng/L in surface water and groundwater, respectively. This
confirms the importance of developing of advanced treatment technologies effective against
organic microcontaminants in drinking water.
Regardless of the PPCP or water sample type, most studies on the occurrence of
pharmaceuticals were conducted only once. Therefore, there is little available knowledge
on PPCP variations in water in relation to seasons and existing conditions. These kinds of
substances have not been monitored on a regular basis in Poland. Based on the gathered
information, it was difficult to identify the trend in terms of water pollution from PPCPs.
Extremely high or low concentrations may result from local conditions or temporary
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actions. Thus, scarce data can be misleading, and moreover, longitudinal studies should be
considered in the future.
7. Conclusions
This review of the current situation in Poland has examined the levels of contamination
from pharmaceuticals and personal care products in the water environment, considering
different types of water samples: raw and treated wastewater, landfill leachate, surface
water, seawater, groundwater and drinking water. All these water environments were
studied in terms of the presence of PPCPs, but the scope of analyses in the research studied
varied significantly depending on the sample type. Several of the analysed results were
single values, providing the only source of information about PPCP concentrations in given
types of water samples.
We confirmed that studies have predominantly focused on the most common PPCP
groups (antibiotics and NSAIDs). Pharmaceuticals often consumed by humans were found
in all types of water samples considered. Although NSAIDs, antibiotics and several other
popular compounds dominated in water samples, the presence of less common substances
in water cannot be excluded. Further research could confirm the PPCPs prevailing in
different parts of the water environment. In particular, more attention should be paid
to landfill leachate and seawater. Although few studies focused on samples from these
sources, they have confirmed that PPCPs might sometimes occur in significant amounts.
According to the review, the highest amounts of PPCPs were reported for wastewater
samples and landfill leachate. The highest concentrations were observed for naproxen
in raw wastewater (551,960 ng/L), and bisphenol A in treated wastewater and landfill
leachate (10,840 ng/L and 2,202,000 ng/L, respectively). Apart from several exceptions,
the quantities of studied substances in natural water (surface water and groundwater)
were considerably lower. Maximum concentrations reached 29,995.5 ng/L for caffeine in
surface water and 17,280 ng/L for DEET in groundwater. However, in many cases, the
reported results did not exceed quantification or detection limits. In seawater, oxolinic
acid dominated (up to 1026 ng/L). Some compounds were also analysed and detected in
drinking water (e.g., widely used substances such as ibuprofen, paracetamol and caffeine
up to 223.6 ng/L, 172.2 ng/L and 158.7 ng/L, respectively). With several exceptions, EDCs
were mostly found to be at levels below the benchmark values suggested for three included
in the proposal for the EU Drinking Water Directive. It is worth noting that there was
no evidence of risks to health posed by PPCPs in drinking water, and these parameters
were included in the directive on the basis of the precautionary principle. Nevertheless,
as consumption of medications is increasing worldwide, higher concentrations of PPCPs
in water might be expected in the future. Development of advanced technologies in both
wastewater and drinking water treatment would minimize the risk of natural water being
contaminated with PPCPs and would enable future environmental quality standards to be
established (and met) for protection of the aquatic environment.
The presence of PPCPs in water is an issue of emerging concern in Poland. The amount
of Polish research on PPCPs is limited, and most studies have only been published in the
last few years. In general, studies on PPCPs in Poland have been single and incidental. The
lack of regular studies and obligatory monitoring prevents us from ascertaining the full
scale of the problem. In the case of wastewater and drinking water, limited data on PPCP
concentrations at successive stages of treatment preclude accurate assessment of removal
efficiencies and thus selection of appropriate technologies. Similarly, it is not feasible to
make predictions or draw detailed conclusions about PPCP behaviour in water. Instead
of random sampling, future research should be conducted repeatedly to ensure proper
understanding of PPCP occurrence in the water environment of Poland.
As currently available data only enable a broad outline to be drawn of the overall
degree of water contamination, future research should be carried out systematically, in-
stead of ceasing after one screening. So far, only one complex screening of PPCPs has
been conducted covering the whole of Poland (carried out in groundwater by the Polish
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Geological Institute National Research Institute). Unfortunately, this did not turn into
systematic monitoring. Implementation of the legislation related to EU-wide monitoring
and inclusion of pharmaceutical substances would definitely contribute to much-needed
development in this field.
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25. Kot-Wasik, A.; Dębska, J.; Namieśnik, J. Transformations, concentrations and determination of pharmaceutical residues in the
environment. In Nowe Horyzonty i Wyzwania w Analityce i Monitoringu Środowiskowym; Namieśnik, J., Chrzanowski, W., Szpinek,
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55. Jagoda, A.; Żukowski, W.; Dąbrowska, B. Caffeine in Cracow Rivers. Czas. Techniczne Śr. 2011, 6, 99–108.
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89. Kamińska, G.; Kudlek, E.; Dudziak, M.; Bohdziewicz, J. Removal of biologically active substances during mechanical-biological
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Diazepam and Sertraline: Phototransformation and Investigation of their Photoproducts in Natural Waters. J. Chromatogr. Sep.
Tech. 2014, 5, 253–264.
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